Protein engineering: a new frontier for biological therapeutics

Area of Science:

• Biochemistry
• Pharmacology
• Biotechnology

Background:

• Protein therapeutics represent a growing class of FDA-approved drugs with significant clinical potential.
• Current protein engineering for therapeutics is advancing, offering better control over drug pharmacokinetics and pharmacodynamics.
• Stimulus-responsive protein therapeutics are designed for targeted metabolism under specific conditions.

Purpose of the Study:

• To review the applications of protein engineering in developing smart, stimulus-responsive drug systems.
• To highlight advancements in controlling drug metabolism and therapeutic action.
• To explore emerging multicomponent smart drug systems and their potential.

Main Methods:

• Review of current literature on protein engineering for drug development.
• Analysis of strategies for stimulus-responsive drug design, including targeted neutralization and prodrugs.
• Examination of emerging systems like antibody-drug conjugates and responsive engineered zymogens.

Main Results:

• Protein engineering enables the creation of tailored therapeutics with built-in biochemical logic.
• Stimulus-responsive systems offer precise control over drug release and activity.
• Emerging multicomponent systems show promise for complex therapeutic challenges.

Conclusions:

• Protein engineering is pivotal in advancing smart therapeutics for improved clinical outcomes.
• Stimulus-responsive drug systems offer a paradigm shift in targeted drug delivery and metabolism.
• Further development in multicomponent systems and network medicine holds significant therapeutic promise.